血尿酸与糖尿病主要并发症关系的研究
本文选题:2型糖尿病 + 血尿酸 ; 参考:《天津医科大学》2017年博士论文
【摘要】:目的 随着2型糖尿病(T2DM)及其并发症患病率的不断上升,T2DM尤其糖尿病的并发症给糖尿病患者的生活质量以及生命健康造成了严重的影响。伴随饮食结构的变化,高尿酸血症的患病率也逐年增加且呈现年龄提前的趋势。2型糖尿病患者由于胰岛素抵抗存在或者胰岛素分泌不足,存在血脂、血糖、蛋白质以及血尿酸的代谢紊乱。本文着重探讨血尿酸和糖尿病主要并发症之间的联系以及血尿酸与其他因素的交互作用对糖尿病主要并发症的影响。方法 为了解2型糖尿病患者管理情况,中国医院协会从2013年5月到8月在我国27个城市81所三甲医院开展横断面调查。6800例2型糖尿病住院患者应邀请参与了本次研究。依据研究对象入选和排除标准,最终6713例患者的资料用于分析。本次研究中糖尿病主要并发症包括急性病并发症(低血糖),慢性心血管并发症和小血管并发症。本次研究中低血糖定义为血糖浓度≤3.9μmol/L并在住院前1个月无任何症状,住院前的一个月内有一次或多次症状性低血糖发作;或者住院前的三个月内有一次或多次的需要他人帮助的症状性低血糖发作。慢性心血管并发症(CVD)定义为先前的冠心病、脑卒中和外周血管病。糖尿病小血管并发症(MVD)定义为糖尿病肾病和糖尿病视网膜病。通过限制性立方样条分析血尿酸和糖尿病主要并发症的联系方式,采用Logistic回归分析血尿酸和糖尿病主要并发症危险性的比值比(OR)及其95%可信区间(95%CI),通过相加交互作用指标(RERI、AP)及其95%CI进行定性和定量分析血尿酸和其他因素的对糖尿病主要并发症的相加交互作用。RERI0和AP0表示因素间具有显著交互作用。结果 最终纳入分析的6713例2型糖尿病患者的平均年龄为56.38±10.55岁,患糖尿病病程的中位数为3.00年(下四分位数:0.41;上四分位数:6.05),研究对象中女性患者比例为43.44%。所有研究对象中,409(6.09%)发生低血糖症状,其中无症状性、中度和重度低血糖的人数及比例分别为25(0.37%)、304(4.53%)和80(1.19%);561(8.36%)患有CVD,其中冠心病、脑卒中和外周动脉病的人数及比例分别为357(5.32%)、106(1.58%)和216(3.21%);408(6.08%)患有MVD,其中糖尿病肾病和糖尿病视网膜病人数及比例分别为220(3.28%)和281(4.19%)。血尿酸和糖尿病主要并发症的联系如下:1.血尿酸和低血糖呈非线性联系;多因素模型中高血尿酸水平(≥283μmol/L)和低血糖发生的OR为1.98(95%CI:1.58-2.48);高血尿酸水平和轻度肾小球滤过率降低(60e GFR≤90 m L/min/1.73 m2)两因素同时存在对低血糖的危险性有相加交互作用,多因素模型中RERI(95%CI)和AP(95%CI)分别为2.11(0.42-3.81)和0.54(0.25-0.82)。2.血尿酸和心血管并发症大致呈线性联系,血尿酸每增加1μmol/L,心血管病危险性增加0.1%;多因素分析模型中高血尿酸水平(SUA≥283μmol/L)和糖尿病心血管并发症发生的OR为1.49(95%CI:1.25-1.78);高血尿酸水平和轻度肾小球滤过率降低(60e GFR≤90 m L/min/1.73 m2)两因素同时存在对心血管并发症的危险性有相加交互作用,多因素模型中RERI(95%CI)和AP(95%CI)分别为1.15(0.05-2.26)和0.48(0.15-0.81);高尿酸水平和低胆红素水平(11.5μmol/L)两因素同时存在对心血管并发症的危险性有相加交互作,多因素模型中RERI(95%CI)和AP(95%CI)分别为4.40(3.25-5.54)和0.84(0.77-0.90)。3.无论单因素还是多因素模型中,血尿酸和小血管并发症呈非线性联系;多因素分析模型中高血尿酸水平(SUA≥283μmol/L)和糖尿病小血管并发症发生的OR为1.35(95%CI:1.04-1.75);高血尿酸水平和轻度肾小球滤过率降低(60e GFR≤90 m L/min/1.73 m2)两因素同时存在对小血管并发症的危险性有相加交互作用,多因素模型中RERI(95%CI)和AP(95%CI)分别为0.87(0.10-1.65)和0.66(0.32-0.99);高尿酸水平和低胆红素水平(11.5μmol/L)两因素同时存在对小血管并发症的危险性有相加交互作,RERI(95%CI)和AP(95%CI)分别为1.06(0.40-1.73)和0.58(0.32-0.84)。讨论 血尿酸和糖尿病主要并发症危险性有关联,血尿酸和低血糖、小血管并发症的联系呈非线性,与心血管并发症的联系大致呈现线性;高血尿酸水平和肾小球肾功能轻度下降对糖尿病主要并发症的危险性有相加交互作用;高血尿酸水平和低血胆红素对糖尿病心血管并发症和小血管并发症的危险性有相加的交互作用。本次研究结果有待于在其他人群,尤其2型糖尿病非住院人群中证实,且因素和并发症间联系的相关机制,以及血尿酸被纳入糖尿病病人血管并发症的危险评分模型后的预测效果也有待于进一步研究。
[Abstract]:Objective with the increasing prevalence of type 2 diabetes (T2DM) and its complications, the complications of T2DM especially diabetes have a serious impact on the quality of life and life and health of diabetic patients. With the change of diet structure, the prevalence of hyperuricemia also increases year by year and presents the trend of age.2 diabetes. The relationship between blood uric acid and the major complications of diabetes and the interaction of blood uric acid and other factors on the main complications of diabetes are discussed in this paper. The method is to understand the type 2 diabetic patients. The Chinese Hospital Association, from May 2013 to August, conducted a cross-sectional survey of 81 three A hospitals in 27 cities in 27 cities in China. The hospitalized patients with type 2 diabetes mellitus should be invited to this study. According to the selection and exclusion criteria of the subjects, the data of the final 6713 patients were used for analysis. The main complications of diabetes in this study were the major complications of diabetes. It includes acute complications (hypoglycemia), chronic cardiovascular complications, and small vascular complications. This study was defined as blood glucose levels less than 3.9 UU mol/L and no symptoms for 1 months before hospitalization, one or more episodes of symptomatic hypoglycemia in one month before hospitalization, or one or more needs within three months before hospitalization. Symptomatic hypoglycemia attacks by others. Chronic cardiovascular complications (CVD) are defined as previous coronary heart disease, stroke, and peripheral vascular disease. Diabetic small vascular complications (MVD) are defined as diabetic nephropathy and diabetic retinopathy. The ratio Ratio (OR) and 95% confidence interval (95%CI) of the risk of major complications of blood uric acid and diabetes were analyzed by Logistic regression. The additive interaction index (RERI, AP) and its 95%CI were used to qualitatively and quantitatively analyze the additive interaction of serum uric acid and other factors on the main complications of diabetes,.RERI0 and AP0. The average age of 6713 patients with type 2 diabetes was 56.38 + 10.55 years old. The median of the course of diabetes was 3 years (the lower four digits, 0.41, the upper four digits 6.05). Among the subjects of the study, the proportion of women in the study was 43.44%., 409 (6.09%) of hypoglycemia symptoms, of which no The number and proportion of symptomatic, moderate and severe hypoglycemia were 25 (0.37%), 304 (4.53%) and 80 (1.19%); 561 (8.36%) had CVD. The number and proportion of coronary heart disease, stroke and peripheral artery disease were 357 (5.32%), 106 (1.58%) and 216 (3.21%), respectively, and the number and proportion of diabetic nephropathy and diabetic retina patients. 220 (3.28%) and 281 (4.19%) respectively. The relationship between blood uric acid and the main complications of diabetes was as follows: 1. the blood uric acid and hypoglycemia showed a nonlinear relationship; the high blood uric acid level (> 283 mol/L) and the occurrence of hypoglycemia in the multifactor model were 1.98 (95%CI:1.58-2.48); the high blood uric acid level and the mild glomerular filtration rate decreased (60E GFR < 90 m L/min/). 1.73 m2) two factors simultaneously had an additive interaction for the risk of hypoglycemia. In the multifactor model, RERI (95%CI) and AP (95%CI) were 2.11 (0.42-3.81) and 0.54 (0.25-0.82).2., respectively, with a linear relationship between blood uric acid and cardiovascular complications. The increase of blood uric acid was 1 micron, and the risk of cardiovascular disease increased by 0.1%; the multifactor analysis model was high. The levels of blood uric acid (SUA > 283 / mol/L) and diabetic cardiovascular complications were 1.49 (95%CI:1.25-1.78); high blood uric acid level and mild glomerular filtration rate (60E GFR < 90 m L/min/1.73 m2) two factors simultaneously had a combined effect on the risk of cardiovascular complications, and RERI (95%CI) and AP (AP) in the multifactor model. 1.15 (0.05-2.26) and 0.48 (0.15-0.81), high uric acid level and low bilirubin level (11.5 micron mol/L) two factors were simultaneously interacted with the risk of cardiovascular complications. RERI (95%CI) and AP (95%CI) in multifactor models were 4.40 (3.25-5.54) and 0.84 (0.77-0.90).3. respectively in single factor or multifactor model, hematuria There was a nonlinear relationship between acid and small vascular complications; the level of high blood uric acid (SUA > 283 mol/L) and OR of diabetic small vascular complications were 1.35 (95%CI:1.04-1.75) in the multifactor analysis model, and two factors of the high blood uric acid level and mild glomerular filtration rate (60E GFR < 90 m L/min /1.73 m2) were at the same time for the risk of small vascular complications. In the multifactor model, RERI (95%CI) and AP (95%CI) were 0.87 (0.10-1.65) and 0.66 (0.32-0.99) in the multifactor model, and the two factors of high uric acid level and low bilirubin level (11.5 mu mol/L) were simultaneously interacted with the risk of small vascular complications, and RERI (95%CI) and AP (95%CI) were 1.06 (0.40-1.73) and 0.58 (0.58), respectively. This is associated with the risk of major complications of blood uric acid and diabetes, blood uric acid and hypoglycemia, a nonlinear relationship between small vascular complications and a linear relationship with cardiovascular complications; high blood uric acid levels and a mild decline in glomerular renal function have a combined effect on the risk of major diabetic complications; high blood uric acid Levels and low blood bilirubin have a combined effect on the risk of cardiovascular complications and small vascular complications in diabetes. This study remains to be confirmed in other populations, especially in non hospitalized people with type 2 diabetes, and the associated mechanisms of factors and complications, and the inclusion of blood uric acid in diabetic vascular complications. The prediction effect after the risk score model still needs further study.
【学位授予单位】:天津医科大学
【学位级别】:博士
【学位授予年份】:2017
【分类号】:R587.2;R589.7
【相似文献】
相关期刊论文 前10条
1 王静,阮芸,徐冬娥,谭擎缨;多项指标联检对诊断早期糖尿病肾病的意义[J];浙江临床医学;2000年04期
2 王玉新,李大启,李公宝,徐琴君;糖尿病肾病患者血清可溶性白细胞介素6受体检测[J];上海免疫学杂志;2001年02期
3 宫雅南,刘冬年,熊玉冰,黄伟文,庄万江;糖尿病足患者糖尿病视网膜病变分析[J];广东医学;2001年06期
4 顾芹,宋守君,李向阳,尤传一;胰激肽原酶肠溶片对早期糖尿病肾病的防治作用[J];中国临床药学杂志;2001年06期
5 曹爱华 ,王瑛 ,李翔;杏丁治疗早期糖尿病肾病疗效观察[J];辽宁实用糖尿病杂志;2001年03期
6 ;中药治疗糖尿病肾病新进展[J];中国中医药信息杂志;2001年04期
7 张桂茹;糖尿病肾病85例临床分析[J];陕西医学杂志;2002年02期
8 侯建明 ,林凤辉 ,张超群;46例2型糖尿病肾病与糖尿病自主神经病变的关系分析[J];福建医药杂志;2002年04期
9 陈文霖;糖尿病饮食[J];医疗保健器具;2002年Z1期
10 孙力,许玲;2型糖尿病患者糖尿病足的危险因素分析[J];山东医药;2002年35期
相关会议论文 前10条
1 张星;许筠;苏建平;张军;程立志;翟晓丽;;糖尿病肾病的临床疗效对比观察[A];第十九次全国中医肾病学术交流会论文汇编[C];2006年
2 杨家茂;;糖尿病肾病防治琐谈[A];全国第二届中医中西医结合肾脏病临床进展学术研讨会论文集[C];2007年
3 丁耀耿;郝桂霞;;糖尿病肾病临床分析[A];全国第二届中医中西医结合肾脏病临床进展学术研讨会论文集[C];2007年
4 张文铠;王志伏;王雪;孙大朋;;糖尿病肾病的治疗现状[A];中华中医药学会第二十一届全国中医肾病学术会议论文汇编(下)[C];2008年
5 倪青;;糖尿病肾病的中西医结合研究[A];第六届全国中西医结合肾脏病学术会议论文汇编[C];2000年
6 孙怡;李健红;宗红燕;;黄芪桂枝五物汤加味治疗糖尿病肾病16例[A];第六届全国中西医结合肾脏病学术会议论文汇编[C];2000年
7 叶军;;糖尿病肾病在儿童时期的早期干预[A];中华医学会第六次全国内分泌学术会议论文汇编[C];2001年
8 杜旭昶;孙志红;闫春芳;刘彩虹;;疏糖丹治疗2型糖尿病50例临床分析[A];第六次中国中西医结合糖尿病学术会议论文汇编[C];2002年
9 于世家;任平;马丽佳;李小娟;郑曙琴;武明东;刘自力;薛丽辉;;糖尿病住院患者1344例回顾性分析[A];第六次中国中西医结合糖尿病学术会议论文汇编[C];2002年
10 郝效槐;魏玫都;崔立俊;;中西并蓄治疗糖尿病肾病[A];第七次中国中西医结合糖尿病学术会议论文汇编[C];2004年
相关重要报纸文章 前10条
1 本报记者 向佳;糖尿病中医药防治项目立足社区[N];中国中医药报;2011年
2 特约记者 鲁海燕;逾八成公众存在糖尿病高危因素[N];家庭医生报;2013年
3 马明愈;现代生活方式导致 糖尿病发病率迅速上升[N];中国妇女报;2005年
4 省立医院内分泌科主任医师 侯建明;糖尿病肾病的防治[N];福建科技报;2004年
5 王文绢 范军星;世界糖尿病日关注焦点:糖尿病并发症[N];健康报;2003年
6 主持人 向红丁博士;糖尿病肾病须早防早治[N];人民政协报;2002年
7 华悦;预防糖尿病,从减肥开始[N];上海中医药报;2004年
8 刘冬梅;肥胖糖尿病第一诱因[N];天津日报;2004年
9 刘燕玲;首部中医专病指南定下糖尿病治则[N];健康报;2007年
10 崔昕;中药防治糖尿病肾病有进展[N];健康时报;2006年
相关博士学位论文 前10条
1 任艳峰;血尿酸与糖尿病主要并发症关系的研究[D];天津医科大学;2017年
2 王晓杰;组蛋白去乙酰化酶4特异性促进糖尿病肾病足细胞损伤[D];山东大学;2015年
3 张永;MiR-346在抗TGF-β信号途径介导的糖尿病肾病发生和发展中的作用机制[D];武汉大学;2015年
4 魏凤江;高尿酸血症、2型糖尿病及糖尿病微血管病变的群体遗传学研究[D];天津医科大学;2015年
5 孙士杰;胱抑素C对2型糖尿病视网膜病变预测价值研究[D];山东大学;2015年
6 龙泓竹;益气养阴通络散结方防治早期糖尿病肾病的临床及实验研究[D];北京中医药大学;2016年
7 姜e,
本文编号:1977315
本文链接:https://www.wllwen.com/yixuelunwen/nfm/1977315.html